Package 70518-3389-0

{"route": ["SUBLINGUAL"], "spl_id": "3a8564e8-d5ec-d4cb-e063-6394a90ad524", "openfda": {"unii": ["56W8MW3EN1", "5Q187997EE"], "rxcui": ["351267"], "spl_set_id": ["072b2c2e-a564-4bb4-8954-9349a7923807"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BLISTER PACK (70518-3389-0)", "package_ndc": "70518-3389-0", "marketing_start_date": "20220316"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "70518-3389_3a8564e8-d5ec-d4cb-e063-6394a90ad524", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "70518-3389", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": "2 mg/1"}], "application_number": "ANDA205601", "marketing_category": "ANDA", "marketing_start_date": "20220316", "listing_expiration_date": "20261231"}